Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 21- Open
- $84.22
- 52-wk high
- $93.42
- High
- $85.65
- 52-wk low
- $46.81
- Low
- $83.25
- Prev close
- $82.98
Smart money
Earnings
Earnings came in 21.9% below what analysts expected.
Financials
What it sold, what it cost, what was left.
| USD | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $110.6M | $120.7M | $154.2M | $194.5M |
| Cost of what it sold | $3.7M | $6.6M | $15.4M | $10.4M |
| Gross profit | $106.9M | $114.1M | $138.8M | $184.1M |
| What it spent | ||||
| Research and development | $111.2M | $112.9M | $142.0M | $126.6M |
| Sales and admin | $129.2M | $137.6M | $158.1M | $163.9M |
| Other operating costs | — | $8.8M | $23.9M | — |
| Total operating expenses | $241.2M | $259.3M | $324.0M | $290.0M |
| What was left | ||||
| Operating profit | -$134.3M | -$145.2M | -$185.2M | -$106.0M |
| Interest on debt | $37.6M | $11.7M | $12.0M | $52.8M |
| Profit before tax | -$181.7M | -$186.5M | -$197.2M | -$166.6M |
| Tax | $2.1M | -$1.5M | — | — |
| Net profit | -$181.9M | -$182.7M | -$197.2M | -$164.0M |
| EBITDA | -$142.7M | -$173.3M | -$180.2M | -$112.6M |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
News
What the news says
Coverage leans bullish
Tone of tracked coverage
Insider Selling: BridgeBio Pharma (NASDAQ:BBIO) CEO Sells 34,980 Shares of Stock
NeutralAug 20Neil Kumar Sells 10,000 Shares of BridgeBio Pharma (NASDAQ:BBIO) Stock
NeutralAug 20Bridgebio Pharma Insider Sold Shares Worth $3,727,251, According to a Recent SEC Filing
Leans bearishAug 20